Subscribe to RSS FeedNews FeedSubscribe to Comments RSS FeedComments

http://www.markethunterclub.com/ 새 둥지로 옮겼습니다.

Home > , > ONTY news out after market

ONTY news out after market

8:41 PM Posted by MH

up 9% in Pre market

Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis

SEATTLE, May 18 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY - News; TSX: ONY - News) today announced the presentation of data demonstrating the effectiveness of Oncothyreon's PX-866 in a preclinical model of pulmonary fibrosis. The data were presented earlier today by William D. Hardie, M.D., Associate Professor, Pulmonary Medicine, Children's Hospital Medical Center, Cincinnati, Ohio, at the American Thoracic Society International Conference in San Diego, California. PX-866 is a small molecule inhibitor of phosphotidylinositol-3 kinase ("PI-3 kinase"), a key point of control of cellular responses including signaling of cell survival and growth, migration and metabolism.

http://finance.yahoo.com/news/Oncothyreons-PX866-is-prnews-15281967.html?.v=45
Labels: ,

1 comments:

  1. 알 said...
    May 19, 2009 at 9:54 AM

    어제 들어가셨죠? 추카드립니다~

Post a Comment

Disclaimer
This site may include market analysis. All ideas, opinions, and/or forecasts, expressed or implied herein, are for informational purposes only and should not be construed as a recommendation to invest, trade, and/or speculate in the markets. Any investments, trades, and/or speculations made in light of the ideas, opinions, and/or forecasts, expressed or implied herein, are committed at your own risk, financial or otherwise.
저자는 올려지는 글에 의해 파생된 손실에 대해 일체의법적, 금전적 책임을 지지 않으며 '주식' 투자에 따른 모든 위험은투자자 본인이 감수해야 합니다